Skip to Content

TEVA 7164 (Tolterodine Tartrate Extended-Release 4 mg)

Pill with imprint TEVA 7164 is Blue, Capsule-shape and has been identified as Tolterodine Tartrate Extended-Release 4 mg. It is supplied by Teva Pharmaceuticals USA, Inc..

Tolterodine is used in the treatment of urinary incontinence; urinary frequency and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Tolterodine 4 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 7164

Tolterodine tartrate extended-release 4 mg TEVA 7164

Tolterodine Tartrate Extended-Release

Imprint
TEVA 7164
Strength
4 mg
Color
Blue
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Urinary antispasmodics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)
00093-7164
Inactive Ingredients
ethylcellulose (7 mPa.s), hypromellose 2910 (6 mPa.s), ferrosoferric oxide, propylene glycol, shellac, sucrose, corn starch, titanium dioxide, triethyl citrate, FD&C Blue No. 1

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.